|
注册号: Registration number: |
ChiCTR2100055029 |
|
最近更新日期: Date of Last Refreshed on: |
2023-01-08 16:42:49 |
|
注册时间: Date of Registration: |
2021-12-30 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
注册信息与研究计划书不符,请联系我们完善注册信息。 间歇性外斜视患者运动融合中枢功能变化及其在术前评估及预后中的应用价值 |
|
Public title: |
Changes of motor fusion center function in patients with intermittent exotropia and its application value in preoperative evaluation and prognosis |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
间歇性外斜视运动融合中枢可塑性变化与发病和转归之间的关系 |
|
Scientific title: |
Changes of motor fusion center function in patients with intermittent exotropia and its application value in preoperative evaluation and prognosis |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张维嘉 |
研究负责人: |
傅涛 |
|
Applicant: |
Zhang Weijia |
Study leader: |
Fu Tao |
|
申请注册联系人电话: Applicant telephone: |
+86 13120257951 |
研究负责人电话:
Study leader's |
+86 18501089133 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
vega0430@163.com |
研究负责人电子邮件: Study leader's E-mail: |
taofu@ccmu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
北京市东城区东交民巷1号 |
研究负责人通讯地址: |
北京市东城区东交民巷1号 |
|
Applicant address: |
1 Dongjiaomin Alley, Dongcheng District, Beijing |
Study leader's address: |
1 Dongjiaomin Alley, Dongcheng District, Beijing |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
首都医科大学 |
||
|
Applicant's institution: |
Capital Medical University |
||
|
研究负责人所在单位: |
首都医科大学附属北京同仁医院 |
||
|
Affiliation of the Leader: |
Beijing Tongren Hospital Affiliated to Capital Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
TRECKY2020-160 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
首都医科大学附属北京同仁医院伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Beijing Tongren Hospital Affiliated to Capital Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2020-12-08 00:00:00 | ||
|
伦理委员会联系人: |
常灏 |
||
|
Contact Name of the ethic committee: |
Chang Hao |
||
|
伦理委员会联系地址: |
北京市东城区东交民巷1号 |
||
|
Contact Address of the ethic committee: |
1 Dongjiaomin Alley, Dongcheng District, Beijing |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
首都医科大学附属北京同仁医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Beijing Tongren Hospital Affiliated to Capital Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
北京市东城区东交民巷1号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
1 Dongjiaomin Alley, Dongcheng District, Beijing |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
国家自然科学基金(82071001) |
||||||||||||||||||||||
|
Source(s) of funding: |
National Natural Science Foundation of China (Grant Nos. 82071001) |
||||||||||||||||||||||
|
研究疾病: |
间歇性外斜视 |
||||||||||||||||||||||
|
Target disease: |
Intermittent Exotropia |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
非随机对照试验 |
||||||||||||||||||||||
|
Study design: |
Non randomized control |
||||||||||||||||||||||
|
研究目的: |
通过功能磁共振(fMRI)检查,分析间歇性外斜视患者视觉中枢的变化,探讨视觉中枢的改变是否可以作为间歇性外斜视术前评估及预后指标,并建立相应评估体系。 |
||||||||||||||||||||||
|
Objectives of Study: |
Through functional magnetic resonance (fMRI) examination, the changes in the visual center of patients with intermittent exotropia were analyzed, and whether the changes in the visual center could be used as preoperative evaluation and prognosis indicators for intermittent exotropia, and a corresponding evaluation system was established. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1.全身发育异常或合并颅脑及神经系统疾病; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Systemic dysplasia or combined craniocerebral and nervous system diseases; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-01-01 00:00:00至 To 2025-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-01-01 00:00:00 至 To 2023-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
Not stated |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Not stated |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
Not stated |
|
Blinding: |
Not stated |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
Not stated 请阅读注册指南中关于 共享原始数据 的内容。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Not stated |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
原始数据记录及病例记录表由研究负责人保存,电子版采用excel及spss软件管理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
All of the original data records and case records are preserved by study leader, and the electronic version records was managed by excel and spss. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |